Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T44282
|
||||
Former ID |
TTDR01185
|
||||
Target Name |
Aldehyde dehydrogenase, mitochondrial
|
||||
Gene Name |
ALDH2
|
||||
Synonyms |
ALDH class 2; ALDH-E2; ALDHI; Aldehyde dehydrogenase; Humanliver mitochondrial aldehyde dehydrogenase; Mitochondrial aldehyde dehydrogenase; ALDH2
|
||||
Target Type |
Clinical Trial
|
||||
Disease | Alcohol use disorders [ICD9: 303; ICD10: F10.2] | ||||
Cerebrovascular ischaemia [ICD9: 434.91; ICD10: I61-I63] | |||||
Substance dependence [ICD10: F10-F19] | |||||
BioChemical Class |
Oxidoreductases acting on aldehyde or oxo group of donors
|
||||
Target Validation |
T44282
|
||||
UniProt ID | |||||
EC Number |
EC 1.2.1.3
|
||||
Sequence |
MLRAAARFGPRLGRRLLSAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPS
TGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLA ALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCG QIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPG FGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADM DWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGP QVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGP VMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQS PFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS |
||||
Drugs and Mode of Action | |||||
Pathways | |||||
KEGG Pathway | Glycolysis / Gluconeogenesis | ||||
Pentose and glucuronate interconversions | |||||
Ascorbate and aldarate metabolism | |||||
Fatty acid degradation | |||||
Valine, leucine and isoleucine degradation | |||||
Lysine degradation | |||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tryptophan metabolism | |||||
beta-Alanine metabolism | |||||
Glycerolipid metabolism | |||||
Pyruvate metabolism | |||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
PathWhiz Pathway | Beta-Alanine Metabolism | ||||
Ethanol Degradation | |||||
Histidine Metabolism | |||||
Valine, Leucine and Isoleucine Degradation | |||||
Pyruvate Metabolism | |||||
Oxidation of Branched Chain Fatty Acids | |||||
Glycine and Serine Metabolism | |||||
Tryptophan Metabolism | |||||
WikiPathways | Tryptophan metabolism | ||||
Fatty Acid Omega Oxidation | |||||
Phase 1 - Functionalization of compounds | |||||
Neurotransmitter Clearance In The Synaptic Cleft | |||||
References | |||||
Ref 523318 | ClinicalTrials.gov (NCT01273337) Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects. U.S. National Institutes of Health. | ||||
Ref 529588 | J Med Chem. 2008 Aug 14;51(15):4482-7. Epub 2008 Jul 10.Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. | ||||
Ref 531635 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. | ||||
Ref 531660 | A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo. Clin Cancer Res. 2011 Dec 1;17(23):7265-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.